Clinical trial
ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation Expanded in Vitro on Amniotic Membrane in Patients With Limbal Stem Cell Deficiency.
NCT02579993 is registered in ClinicalTrials.gov with Instituto de Oftalmología Fundación Conde de Valenciana as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation Expanded in Vitro on Amniotic Membrane in Patients With Limbal Stem Cell Deficiency.
- Lead sponsor
- Instituto de Oftalmología Fundación Conde de Valenciana
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- March 31, 2015
- Completion date
- March 31, 2018
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.